NCT06202781 2024-01-12
Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy
Chinese PLA General Hospital
Unknown
Clinical Trials
13 trialsNCT05913583 2023-06-22
Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT05609695 2023-01-31
Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeted Drugs / Locoregional Therapy in the Treatment of Hepatocellular Carcinoma
Sun Yat-sen University
Unknown
NCT05638425 2022-12-06
Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases
Xiangya Hospital of Central South University
Unknown
NCT05549336 2022-09-22
Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT05420922 2022-06-15
Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC
Tongji Hospital
Unknown
NCT04922541 2021-06-10
Multi-center Observational Study on the Progression of Atherosclerotic Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT04913896 2021-06-04
CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy
The First Hospital of Jilin University
Unknown
NCT04137588 2021-02-24
Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
Peking University Cancer Hospital & Institute
Unknown
NCT04629027 2021-02-24
Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLC
Peking University Cancer Hospital & Institute
Unknown
NCT04419441 2020-09-16
ICI-RT-1
Ospedale Maggiore Di Trieste
Unknown
NCT04115410 2020-05-28
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
Sungkyunkwan University
Unknown
NCT04355806 2020-04-21
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors
Shanghai Pulmonary Hospital, Shanghai, China
Unknown